The Sangamo Domain

Vital Information for Sangamo Therapeutics (SGMO) Investors

Wednesday, March 9, 2016

IVPRP - What's next?


Posted by Sangaman501 at 7:38 AM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Blog Archive

  • ►  2017 (26)
    • ►  August (1)
    • ►  July (4)
    • ►  June (3)
    • ►  May (3)
    • ►  April (5)
    • ►  March (1)
    • ►  February (6)
    • ►  January (3)
  • ▼  2016 (77)
    • ►  December (2)
    • ►  November (4)
    • ►  October (6)
    • ►  September (5)
    • ►  August (2)
    • ►  July (5)
    • ►  June (3)
    • ►  May (4)
    • ►  April (4)
    • ▼  March (8)
      • Change to Criteria in HSPC HIV Trial
      • Blood - New Publication
      • New Job Postings at Sangamo
      • IVPRP - What's next?
      • Sangamo Slide Shows it's Superiority
      • Dana Carroll - A Perspective on the State of Genom...
      • Targeted gene addition in human CD34+ hematopoieti...
      • Sangamo BioSciences Announces Presentation At The ...
    • ►  February (8)
    • ►  January (26)
  • ►  2015 (204)
    • ►  December (29)
    • ►  November (24)
    • ►  October (17)
    • ►  September (22)
    • ►  August (14)
    • ►  July (10)
    • ►  June (12)
    • ►  May (33)
    • ►  April (33)
    • ►  March (10)
Simple theme. Powered by Blogger.